C677t polymorphism of the methylentetrahydrofolate reductase gene in mothers of children affected with neural tube defects;Polimorfismo C677t del gen de la metilentetrahidrofolato reductasa en madres de niños afectados con defectos del tubo neural

Investigacion Clinica (Venezuela)

Volumn 56, Issue 3, 2015, Pages 284-295

  de Machín, Alisandra Morales ^a   Méndez, Karile ^a   Solís, Ernesto ^a   Fajardo, Lisbeth Borjas ^a   Bracho, Ana ^a   Hernández, María Luisa ^a   Negrón, Aimara ^a   Delgado, Wilmer ^a   Sánchez, Yanira ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

MTHFR C677T polymorphism; Neural tube defect

Indexed keywords

METHYLENETETRAHYDROFOLATE DEHYDROGENASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; METHYLENETETRAHYDROFOLATE DEHYDROGENASE GENE; NEURAL TUBE DEFECT; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; ADOLESCENT; ADULT; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; NEURAL TUBE DEFECTS; NEWBORN; PREGNANCY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEURAL TUBE DEFECTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 84946716997     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Stevenson R, Seaver L, Collins J, Dean J. Neural tube defects and associated anomalies in South Carolina. Birth Defects Res Part A. 2004; 70: 554-558
2. Czeizel A, Dudás I, Paput L, Bánhidy F. Prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins?. Ann Nutr Metab 2011; 58: 263-271
3. Van Der Put N, Van Straaten H, Trijbels F, Blom H. Folate, homocysteine and neural tube defects: An over view. Exp Biol Med 2001; 226 (4): 243-270
4. Greene N, Stanier P, Copp A. Genetics of human neural tube defects. Hum Mol Genet 2009; 18: 113-129
5. Greene N, Copp A. Development of the vertebrate central nervous system: formation of the neural tube. Prenat Diagn 2009; 29: 303-311
6. Mitchell L. Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet 2005; 135: 88-94
7. Au K, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of Spina bifida and other neural tube defects. Dev Disabil Res Rev 2010; 16(1): 6-15
8. Hernández M, Romero M, Morales A, Angarita M, Silva Ch, Delgado W., et al. Defectos del tubo neural en productos de abortos espontáneos. Rev Obstet Ginecol Venez 2009; 69(1):12-19
9. Nussbaum RL, Mclnnes RR, Willard HF. Genética de las enfermedades comunes con herencia compleja. En: Thompson & Thompson. Genética en medicina. 7a edición. España: Editorial Elsevier Masson; 2008.p.151-174
10. Martinez L, Delgado I, Valdéz R, Ortíz R, Rojas A, Limón C, Sánchez M, Ancer J, Barrera H, Villarreal J. Folate levels and N5, N10 Methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: A case-control study. Arch Med Res 2001; 32: 277-282
11. Smithells R, Sheppard S, Schorah C. Vitamin deficiencies and neural tube defects. Arch Dis Child 1976; 51: 944-950
12. Smithells R, Sheppard S, Schorah C, Seller M, Nevin N, Harris R, Read A, Fielding D. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 1981; 56: 911-918
13. Sheppard S, Nervin N, Seller M, Wild J, Smithells R, Read A, Harris R, Fielding D, Schorah C. Neural tube defect recurrence after partial vitamin supplementation. J Med Genet 1989; 26: 326-329
14. Milunsky A, Jick H, Jick S, Bruell C, MacLaughlin D, Rothman K. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262: 2847-2852
15. Shaw G, Schaffer D, Velic E, Morland K, Harris J. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995; 6: 219-226
16. Martínez L, Limón C, Valdez R, Sánchez M, Villarreal J. Efecto de la administración semanal de ácido fólico sobre los valores sanguíneos. Salud Públ México 2001; 43 (2): 103-107
17. Morris J, Wald N. Quantifying the decline in the birth prevalence of neural tube defects in England and Wales. J Med Screen 1999; 6: 182-185
18. Castilla E, Orioli I, López J, Dutra M, Nazer J. Latin American collaborative study of congenital malformations (ECLAMC). Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet 2003; 123A: 123-128
19. Shurtleff D. Epidemiology of neural tube defects and folic acid. Cerebrospinal Fluid Res 2004; 1: 5
20. Corral E, Moreno R, Pérez G, Ojeda M, Valenzuela H, Reascos M, Sepúlveda W. Defectos congénitos cráneo-encefálicos: variedades y respuesta a la fortificación de la harina con ácido fólico. Rev Méd Chile 2006; 134(9): 1129-1134
21. Nazer H, Cifuentes O, Aguila R, Juárez M, Cid M, Godoy M. Effects of folic acid fortification in the rates of malformations at birth in Chile. Rev Med Chile 2007; 135: 198-204
22. Calvo E, Biglieri A. Impacto de la fortificación con ácido fólico sobre el estado nutricional en mujeres y la prevalencia de defectos del tubo neural. Arch Argent Pediatr 2008; 106(6): 492-498
23. Barboza M, Umaña L. Impacto de la fortificación de alimentos con ácido fólico en los defectos del tubo neural en Costa Rica. Rev Panam Salud Pública 2011; 30 (1): 1-6
24. Agüero O, Layrisse M. Megaloblastic anemia of pregnancy in Venezuela. Am J Obstet Gynecol 1958; 76: 903-908
25. Layrisse M, Agüero O, Blumenfeld N, Wallis H, Dugarte I, Ojeda A. Megaloblastic anemia of pregnancy: characteristics of pure megaloblastic anemia and megaloblastic anemia associated with Iron deficiency. Blood 1960; 15: 724-740
26. Diez-Ewald M. Anemia del embarazo. Revisión. Invest Clin 1991; 32(1): 41-54
27. Molina R, Diez-Ewald M. Anemia nutricional del embarazo en Maracaibo. Venezuela. Invest Clin 1971; 39: 15-28
28. Diez-Ewald M, Molina R. Iron and folic acid deficiency during pregnancy in western Venezuela. Am J Trop Med Hyg. 1972; 587-591
29. Molina R, Diez-Ewald M, Fernández G, Velazquez N. nutricional anaemia during pregnancy. A comparative study of two socio-economic classes. J Obstet Gynecol Brit Comm 1974; 81(6): 454-458
30. Diez-Ewald M, Fernández G, Oberto J, Molina R. Nutritional anemia during pregnancy. A study in a middle class population treated with placebo. Invest Clin 1975; 16 (2): 51-59
31. Diez-Ewald M, Vizcaíno G, Zambrano- Rodríguez N. Niveles de ácido fólico y vitamina B12 en habitantes de la ciudad de Maracaibo. Invest Clin 1987; 28 (2): 75-85
32. Carruyo-Vizcaíno C, Diez-Ewald M, Vizcaíno G, Arteaga-Vizcaíno M. Concentración de hemoglobina y nutrientes en una población estudiantil adolescente de bajos recursos económicos. Relación con el rendimiento académico. Invest Clin 1990; 31 (4): 189-205
33. Carruyo-Vizcaíno C, Vizcaíno G, Diez-Ewald M, Arteaga-Vizcaíno M, Torres-Guerra E. Concentración de hemoglobina y nutrientes en adolescentes de clase social media. Relación con el rendimiento académico. Invest Clin 1995; 36 (3): 117-130
34. Diez-Ewald M, Torres E, Layrisse M, Leets I, Vizcaíno G, Arteaga-Vizcaíno M. Prevalence of anemia, iron, folic acid and vitamina B12 deficiency in two Bari indian communities from Western Venezuela. Invest Clin 1997; 38(4): 191-201
35. Diez-Ewald M, Torres-Guerra E, Leetz I, Layrisse M, Vizcaíno G, Arteaga-Vizcaíno M. Anemia en poblaciones indígenas del occidente de Venezuela. Invest Clin 1999; 40 (3): 191-202
36. García-Casal M, Landaeta M, Osorio C, Leets I, Matus P, Fazzino F, Marcos E. Ácido fólico, vitamina B12 en niños, adolescentes y mujeres embarazadas en Venezuela. An Venez Nutr 2005; 18 (2): 1-10
37. Van Der Put N, Gabreëls F, Stevens E, Smeitink J, Trijbels F, Eskes T, Van den Heuvel L, Blom H. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-1051
38. Goyette P, Sumner J, Milos R, Duncan A, Rosenblatt D, Matthews R, Rozen R. Human methylene-tetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994; 7: 195-200
39. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LA. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10 (1): 111-113
40. Mattson M, Shea T. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neuro Sci. 2003; 26: 137-146
41. Jacques P, Bostom A, Williams R, Ellison C, Eckfeld J, Rosemberg I, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations. Circulation. 1996; 93: 7-9
42. Vizcaíno G, Diez-Ewald M, Herrmann F, Schuster G, Pérez-Requejo J. Relationships between homocysteine, folate and vitamina B12 levels with the methylenetetrahydrofolate reductase poly-morphism, in Indians from Western Venezuela. Thromb Haemost. 2001; 85: 186-187
43. Vizcaíno G, Diez-Ewald M, Herrmann F, Schuster G, Torres-Guerra E, Arteaga-Vizcaíno M. La homocisteínemia y su relación con el polimorfismo de la mutilentetrahidrofolato reductasa en varios grupos étnicos del occidente de Venezuela. Invest Clin. 2005; 46 (4):347-355
44. Unfried G, Griesmacher A, Weismûller W, Nagele Fritz, Huber J, Tempfer C. The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet Gynecol. 2002; 99: 614-619
45. Rosenquist T. Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid. Proc Natl Acad Sci USA. 1996; 93: 15227-15232
46. Suárez-Obando F, Ordóñez A, Zarante I. Defectos del tubo neural y ácido fólico: patogenia, metabolismo y desarrollo embriológico. Revisión de la literatura. Rev Colomb Obstet Ginecol. 2010; 60: 49-60
47. Pineda-Del Villar L, Navarro-Serrano G, Del Villar A. Defectos del tubo neural en el hospital Pedro Garcia Clara. Estado Zulia. Venezuela. Invest Clin. 1993; 34(1): 41-52
48. Gustincich S, Carminci P, Del Sal G, Mamfiolelli G, Schneider C. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques. 1991; 11: 300-302
49. Pierce B. Genética poblacional y evolutiva. En: Genética un enfoque conceptual. 2da. Edición. Editorial Médica Panamericana, SA. 2006. 676-720
50. Iniesta R, Guinó E, Moreno V. Análisis estadístico de polimorfismos genéticos en estudios epidemiológicos. Gac Sanit. 2005; 19 (4): 333-341
51. Pitkin R. Folate and neural tube defects. Am J Clin Nutr. 2007; 85(Suppl): 285-288
52. Shields D, Kirke P, Mills J, Ramsbottom D, Molloy A, Burke H, Weir D, Scott J, Whitehead A. The thermolabile variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum. Genet. 1999; 64: 1045-1055
53. Padmanabhan R. Etiology, patogénesis and prevention of neural tube defects. Congenital Anomalies. 2006. [citado 11 Noviembre 2012]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1741-4520.2006.00104.x/pdf
54. Martínez de Villarreal L, Villarreal J, Arredondo P, Hernández R, Velazco M, Ambriz R, Herrera J, Yañez J, Morales J, Treviño M, Limón A, Guzmán A, Bárcenas M, Cepeda J, Sánchez A, Hernández R, García J, Garza J, Tijerina M, García C, Negrete R. Decline of neural tube defects cases alter a folic acid campaign in Nuevo León, México. Teratology. 2002; 66: 249-256
55. Stegmann K, Ziegler A, Ngo E, Kohlschmidt N, Schröter B, Ermert A, Koch M. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 1999; 87: 23-29
56. Mornet E, Muller F, Leavoisé A, Delezoide A, Col J, Simón B, Serre J. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet. 1997; 100: 513-514
57. Gutiérrez J, Pérez F, Calvo M, Tamparillas M, Gracia J. Implicación de los polimorfismos C677T y A1298C del gen MTHFR en el desarrollo de los defectos del tubo neural en la población española. Med Clin (Barc) 2003; 120 (12): 441-445
58. Erdogan MO, Yildiz SH, Solak M, Eser O, Cosar E, Eser B, Koken R, Buyukbas S. C677T polymorphism of the methylenetetrahydrofolate reductase gene does not affect folic acid, vitamin B12, and homocysteine serum levels in Turkish children with neural tube defects. Genet Mol Res 2010 Jun 22; 9(2):1197-203
59. Eser B, Cosar M, Eser O, Erdogan MO, Aslan A, Yildiz H, Boyaci G, Buyukbas S, Solak M. 677C>T and 1298A>C polymorphisms of methylenetetrahydropholate reductase gene and biochemical parameters in Turkish population with spina bifida occulta. Turk Neurosurg. 2010; 20(1):9-15
60. Alvarez A, D’Almeida V, Vergani N, de Oliveira A, de Lima F, Brunoni D. Methylenetetrahydrofolate reductase (MTHFR): Incidence of mutations C677T and A1298C in brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet 2003; 119A: 20-25
61. Nitsche F, Alliende M, Santos J, Pérez F, Santa María L, Hertrampf D, Cortés F. Frecuencia del polimorfismo C677T de la 5.10-metilentetrahidrofolato reductasa (MTHFR) en mujeres chilenas madres de afectados con espina bífida y en controles normales. Rev Méd Chile 2003; 131: 1399-1404
62. Parle-McDermott A, Mills J, Kirke P, O’Leary V, Swanson D, Pangilinan F, Conley M, Molloy A, Cox C, Scott J, Brody L. Analysis of the MTHFR 1298A→C and 677C→T polymorphisms as risk factors for neural tube defects. J Hum Genet 2003; 48: 190-193
63. Kirke P, Mills J, Molloy A, Brody L, O’Leary V, Daly L. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ. 2004; 328(7455): 1535-1536
64. Van Der Put N, Steegers-Theunissen R, Frosst P, Trijbels F, Eskes T, Van den Heuvel L, Mariman E, Den Heyer M, Rozen R, Blom H. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346 (8982): 1070-1071
65. Pietrzyk J, Bik-Multanowski M, Sanak M, Twardowska M. Polymorphisms of the 5, 10-methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida. J Appl Genet 2003; 44(1): 111-113
66. De Franchis R, Buoninconti A, Mandato C, Pepe A, Sperandeo MP, Del Gado R, Capra V, Salvaggio E, Andria G, Mastroiacovo P. The C677T mutation of the 5,10-Methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet. 1998; 35(12):1009-1013
67. Boduroglu K, Alanay Y, Alikasifoglu M, Aktas D, Tuncbilek E. Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population. Turk J Pediatr 2005; 47 (4): 327-333
68. Blanco J, Lacasaña M, García R, Borja V, Hernández C, Aguilar C. Methylenetetrahydrofolate reductase gene polymorphisms and the risk of anencephaly in Mexico. Mol Hum Reprod 2007; 13(6):419-24
69. García Fragoso L, García-García I, De la Vega A, Renta J, Castilla C. Presence of the 5,10-Methylenetetrahydrofolate Reductase C677T mutation in Puerto Rican patients with neural tube defects. J Child Neurol 2002; 17:30-32
70. Van Der Put N, Eskes T, Blom H. Is the common 677C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A metaanalysis. Q J Med. 1997; 90: 111-115
71. Yan L, Zhao L, Long Y, Zou P, Ji G, Gu A, Zhao P. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: Evidence from 25 case-control studies. Plos One 2012; 7: e41689
72. Zhang T, Lou J, Zhong R, Wu J, Zou L, Sun Y, Lu X, Liu L, Miao X, Xiong G. Genetic variants in the folate pathway and the risk of neural tube defects: A meta-analysis of the published literature. Plos One 2013; 8: e59570
73. Molina R, Diez-Ewald M. Efectos de la terapeútica con hierro y hierro-folato en la anemia nutricional de la embarazada. Comunicación preliminar. Invest Clin 1972; 13(2): 44-57
74. Diez-Ewald M, Fernández G, Velásquez N, Molina R. Importancia de la administración prenatal de ácido fólico en el estado hematológico de la madre y el recién nacido. Invest Clin 1973; 14(2): 58-73
75. Diez-Ewald M, Fernández G, Bonilla E, Portillo B, Vizcaíno G, Machado H. Concentraciones séricas de ácido fólico y cinc en suero materno y cordón umbilical. Influencia en el desarrollo del embarazo y el parto y condiciones del recién nacido. Invest Clin 1988; 29(4): 205-217
76. Diez-Ewald M. ¿Por qué ácido fólico? Editorial. Invest Clin 2000; 41(1): 1-2
77. Department of Health and Human Services: Public Health Service. Recommendations for the use of folic acid to reduce the number of cases of Spina bifida and other neural tube defects. MMWR 1992; 41 (RR-14): 1-7
78. MRC Vitamin Study Research Group. Prevention of neural tube defect: results of The Medical Research Council Vitamin Study. Lancet 1991; 338: 131-137
79. Mosley B, Cleves M, Siega-Riz A, Shaw G, Canfield M, Kim Waller D, Werler M, Charlotte A. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 2009; 169: 9-17